World Health Organization definition of myocardial infarction: 2008-09 revision

International Journal of Epidemiology

Volumn 40, Issue 1, 2011, Pages 139-146

  Mendis, Shanthi ^a   Thygesen, Kristian ^b   Kuulasmaa, Kari ^c   Giampaoli, Simona ^d   Mahonen, Markku ^c   Blackett, Kathleen Ngu ^e   Lisheng, Liu ^f  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^e UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^f FUWAI HOSPITAL   (China)

Author keywords

Atherosclerosis; Clinical diagnosis; Epidemiology; Heart disease; Ischeamic; Myocardial infarction

Indexed keywords

BIOLOGICAL MARKER;

BIOMARKER; CARDIOVASCULAR DISEASE; EPIDEMIOLOGY; WORLD HEALTH ORGANIZATION;

ANGINA PECTORIS; ANGIOCARDIOGRAPHY; ARTICLE; AUTOPSY; DIAGNOSTIC TEST; DISEASE REGISTRY; ELECTROCARDIOGRAM; HEART INFARCTION; HUMAN; PATIENT MONITORING; PRIORITY JOURNAL; Q WAVE; RECURRENT DISEASE; ST SEGMENT ELEVATION; UNSTABLE ANGINA PECTORIS; WORLD HEALTH ORGANIZATION;

AUTOPSY; BIOLOGICAL MARKERS; CORONARY ANGIOGRAPHY; ELECTROCARDIOGRAPHY; HUMANS; MYOCARDIAL INFARCTION; WORLD HEALTH ORGANIZATION;

EID: 79952060499     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dyq165     Document Type: Article

References (21)

1. World Health Organization. Reducing Risks, Promoting Healthy Life. WHO Report. Geneva: WHO, 2002.
2. World Health Organization. World Health Statistics 2008. Geneva: WHO, 2008.
3. World Health Organization. Prevention of Cardiovascular Disease: Guidelines for Assessment and Management of Total Cardiovascular Risk. Geneva: WHO, 2007.
4. World Health Organization. Preventing Chronic Diseases-A Vital Investment. Geneva: WHO, 2005.
5. Yusuf S, Hawken S, Ounpuu S et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004;364:937-52.
6. World Health Organization. Hypertension and coronary heart disease: classification and criteria for epidemiological studies. First Report of the Expert Committee on Cardiovascular Diseases and Hypertension. Geneva: WHO, 1958.
7. World Health Organization. Myocardial Infarction Community Registers. Public Health in Europe, Paper No. 5, Regional Office for Europe. Copenhagen: WHO, 1976.
8. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature. Nomenclature and criteria for diagnosis of ischemic heart disease. Circulation 1979;59:607-9.
9. World Health Organization (WHO/MNC/82, Rev. 1). Proposal for the Multinational Monitoring of Trends and Determinants in Cardiovascular Disease and Protocol (MONICA Project). Geneva: WHO, 1983.
10. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P et al. for the World Health Organization MONICA Project. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project: registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 1994; 90:583-12.
11. Tunstall-Pedoe H (ed), prepared by Tunstall-Pedoe H, Kuulasmaa K, Tolonen H, Davidson M, Mendis S, for the WHO MONICA Project. MONICA Monograph and Multimedia Source Book. The World's Largest Study of Heart Disease, Stroke, Risk Factors and Population Trends (1979-2002). World Health Organization, Geneva, 2003.
12. Joint European Society of Cardiology/American College of Cardiology Committee. Myocardial infarction redefined: a consensus document of the Joint EUROPEAN Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 2000;21:1502-13.
13. Luepker RV, Apple FS, Christenson RH et al. Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute. Circulation 2003;108:2543-49.
14. Thygesen K, Alpert JS, White HD, on behalf of the joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction. Eur Heart J 2007;28:2525-38.
15. World Health Organization. Global Initiative for Scaling up Management of Chronic Diseases. Report of a WHO Meeting, Cairo, Egypt, 11-13 December. Geneva: WHO, 2005.
16. World Health Organization. Social Determinants of Cardiovascular Disease. Geneva: WHO, 2008.
17. Prineas R, Crow R, Blackburn H. The Minnesota Code Manual of Electrocardiogrphic Findings: Standards and Procedures for Measurement and Classification. Littleton, MA: John Wright-PSG, Inc, 1982. http://www.sph.umn.edu/cpi/ecg/mncode.pdf (2 September 2010, date last accessed).
18. Jaffe AS, Babuin L, Apple FS. Biomarkers in acute cardiac disease. J Am College Cardiol 2006;48:1-11.
19. French JK, White HD. Clinical implications of the new definition of myocardial infarction. Heart 2004;90: 99-106.
20. Roger V, Killian JM, Weston SA et al. Redefinition of myocardial infarction: prospective evaluation in the community. Circulation 2006;114:790-97.
21. Salomaa V, Ketonen M, Koukkunen H et al. The effect of correcting for troponins on trends in coronary heart disease events in Finland during 1993-2002; the FINAMI study. Eur Heart J 2006;27: 2394-99.